Global Health · NSE: MEDANTA · BSE: 543654
Q2 FY24 results · Jul–Sep 2023
Global Health reported revenue from operations of ₹843.94 crore and net profit of ₹125.16 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 843.94 | — | — | 773.04 | +9.2% |
| Other income | 20.75 | — | — | 21.46 | −3.3% |
| Total income | 864.69 | — | — | 794.50 | +8.8% |
| Profit before tax | 170.60 | — | — | 141.04 | +21.0% |
| Net profit for the period | 125.16 | — | — | 102.01 | +22.7% |
| EPS, basic (₹) | 4.66 | — | — | 3.80 | +22.6% |
| Net margin (%) | 14.8 | — | 13.2 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 580.15 | — | — | 544.59 | +6.5% |
| Other income | 26.24 | — | — | 33.20 | −21.0% |
| Total income | 606.38 | — | — | 577.79 | +4.9% |
| Profit before tax | 126.89 | — | — | 115.74 | +9.6% |
| Net profit for the period | 95.10 | — | — | 86.21 | +10.3% |
| EPS, basic (₹) | 3.54 | — | — | 3.21 | +10.3% |
| Net margin (%) | 16.4 | — | 15.8 |
Consolidated
- Filed with BSE
- 22 Nov 2023, 15:15 IST
- Board meeting
- 09 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 22 Nov 2023, 15:15 IST
- Board meeting
- 09 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE